maternal blood glucose concentrations of 4.3 f 0.1 and 4.2 f 0.1 mmol/l. During hyperglycemic clamps, maternal glycemia was raised to 5.5 mmol/liter, a value similar to that during a meal in the rat. In this condition, the rate of placental glucose utilization at 19 days of gestation was increased by 85%. This was due not only to hyperglycemia but also to glucose-induced hyperinsulinemia. Indeed during hyperinsulinemic euglycemic clamps, placental glucose utilization showed a dose-response relationship to insulin (400 and 5000 pU/ml). At 21 days of gestation, placental glucose utilization was not affected by hyperglycemia or by hyperinsulinemia suggesting that in term placenta, glucose metabolism is no longer regulated. When 19-day pregnant rats were fasted for 48 and 96 h, the resulting low blood glucose and plasma insulin concentrations and the high ketone body concentrations induced, respectively, a 40 and 47% reduction of placental glucose utilization. The decrease in placental glucose utilization probably was due to both maternal hypoglycemia and long term adaptation to hyperketonemia. Indeed, the acute hyperketonemia in fed rats did not alter glucose utilization rate in placenta at 19 days of gestation. These data suggest that glucose metabolism in the preterm rat placenta is modulated in vivo by the maternal metabolic environment, particularly by maternal blood glucose and insulin concentrations. The preterm rat placenta is thus an insulin sensitive tissue. The placenta is an organ that is involved in the uptake and the transfer of energy substrates to the fetus. Both processes are dependent on placental blood flow and maternal substrate availability. The concentration of energy substrates in the maternal circulation affects the rate of fetal growth (1-4). In addition placental metabolism is an important determinant of normal fetal growth. The restriction of placental transfer of nutrients by reduction of placental size or placental blood flow reduces fetal growth (5-8). The function of the placenta in the nutrient transfer to fetuses has been extensively studied (review in Ref. 9). However, the contribution of different fuels to placental metabolism is not entirely clear (10).
The aim of the present study was to measure placental glucose utilization in vivo in the rat under various physiological conditions. Placental substrate availability was modified by maternal fasting and by inducing acute maternal hyperglycemia and hyperketonemia. Insulin sensitivity of the placenta was studied by using maternal hyperinsulinemic euglycemic clamps. The experiments were performed in 19-and 21-day pregnant rats to take into account the aging process in the placenta.
MATERIALS AND METHODS

Animals.
Female rats of the Wistar strain bred in our laboratory were used. They were housed at 24" C with light from 07.00 to 19.00 h. They had free access to water and food pellets (U.A.R. 103, Epinay, France; carbohydate 65%, fat l l % , and protein 24% of total energy) unless otherwise stated. The rats were studied on day 19 and 2 1 of pregnancy. The stage of pregnancy was determined as described previously (1 I). Pregnant rats were anesthetized with pentobarbital (30 mg/kg body weight ip). One carotid artery was catheterized and a tracheotomy was performed. Body temperature was maintained at 38" C. Infusions were made through the maternal saphenous vein. Fetal blood was sampled via axillary vessels after maternal laparotomy (1 1).
In vivo measurements of the rate of 2-deoxyglucose accumulation by rat placenta. The method used was derived from the technique of Sokoloff et al. (12) and described previously (13). In brief, 30 rCi of 'H-2DG 20 Ci/mmol (CEA, Saclay, France) were injected in a maternal vein. Maternal arterial blood was sampled at 1, 3, 5, 10, 15, 20, 30, 40, and 60 min after the injection. The measurement of specific activity was performed on blood samples (50 ~1 ) deproteinized with ZnS04/Ba(OH)2 and centrifuged. 3H-2DG was determined using a scintillation counter Betamatic 2, Kontron, Velizy, France) and blood glucose concentration using glucose oxidase method (Boehringer, Meylan, France). The integral of specific activity 'H-2DG/glucose was calculated over 60 min. Plasma insulin was determined by radioimmunoassay (14) and ketone bodies were measured enzymatically on aliquots of the last blood samples (15). After the last blood sampling, rats were killed by cervical dislocation and placentas were excised. The amount of 3H-2DG-6-phosphate accumulated in the placenta was determined by differential precipitation in Somogyi reagent and in 6% HC1 0 4 on aliquots of tissues digested for 1 h at 609 C in 1 M NaOH and neutralized.
In preliminary experiments, the specific activity 'H-2DG/ glucose was measured simultaneously in maternal and fetal blood. The difference between maternal and fetal integral of 3H-2DG/glucose specific activity is the result of the discrimination of 2DG against glucose by the placenta because axillary blood of fetus represents efferent blood from placenta (16). The ratio of 484 LETURQU the integral of maternal arterial blood 3H-2DG/glucose to fetal blood 3H-2DG/glucose was 0.87 f 0.02 (n = 6).
Glucose utilization rate was calculated as the amount of 3H-2DG-6-phosphate accumulated in the placenta divided by the integral of 3H-2DG/glucose specific activity in the blood and by the discrimination constant.
3H-2DG 6 phosphate in placenta Glucose utilization
The results were expressed in nmol of glucose utilized per min and per g of placenta. Placental glucose utilization rates were measured in steady state conditions for blood glucose concentration and glucose utilization during different metabolic situations, in the fed state and after 48 h or 96 h of maternal fasting and during euglycemic hyperinsulinemic clamps and hyperglycemic clamps as well as during P-hydroxybutyrate infusions to fed pregnant rats. Maternal euglycemic hyperinsulinemic clamp experiments (14, 17) were performed at two different insulin infusion rates: 0.4 and 3 U/kg/h, the euglycemia was maintained by an appropriate glucose infusion: 22 + 3 and 49 + 2 pmol/min, respectively, in 19-day pregnant rats. In 21-day pregnant rats infused with insulin at the rate of 3 U/kg/h an exogenous infusion of glucose at the rate of 4 1 + 3 pmol/min was necessary to maintain euglycemia (Tables 1 and 2 ). The plateau of exogenous glucose infusion was achieved by 30-40 min and was maintained during the measurement of glucose utilization by 3H-2DG technique. Maternal hyperglycemic clamp experiments were performed by infusing exogenous glucose at a rate of 37 + 3 pmol/min in 1 9-day and 29 -+ 3 pmol/min in 2 1-day pregnant rats in order to reach a steady state blood glucose concentrations of 5.5 mmol/liter. Plasma glucose concentrations were recorded every 5 min with a Yellow Springs Glucose Analyzer YSI 23A (Yellow Springs, OH). Steady state glucose concentrations and glucose infusion rates were reached within 15 min onward.
Sodium D-L P-hydroxybutyrate (Sigma, St Louis, MO) was infused during 2 h to fed pregnant rats at a rate of 5 pmol/h/g in order to raise the P-hydroxybutyrate concentration two-fold over basal values. Steady state maternal P-hydroxybutyrate concentrations (2-3 mmol/liter) were reached after 30 min onward (results not shown). The glucose utilization index was measured during the last hour of P-hydroxybutyrate infusion. This rate of 0-hydroxybutyrate infusion was chosen since it did not increase lactatemia. In preliminary experiments maternal lactatemia was increased two-fold when P-hydroxybutyrate was infused at the rate of 10 pmol/h/g (result not shown).
Statistics. Results are presented as means f SEM of six to nine pregnant rats. Statistically significant differences were assessed using non parametric Mann-Whitney test.
RESULTS
Effects of hyperglycemic clamp. In the basal state, placental glucose utilization was 139 + 5 nmol/min/g on day 19 and 155 + 22 nmol/min/g on day 21 of gestation ( Fig. I) . Hyperglycemic clamps were performed to produce an increase of glycemia and insulinemia similar to that observed during a meal in the rat (1 8) (Tables 1 and 2 ). During hyperglycemic clamps a 85% increase in placental glucose utilization rate was observed in placenta from 19-day pregnant rats ( p < 0.01) whereas no significant modification was obtained in placenta from 2 1-day pregnant rats (Fig. 1) . The changes of fetal blood glucose and plasma insulin levels (Tables 1 and 2) could not explain the difference observed between 19-and 21-day placenta in the basal state as well as during clamp experiments.
Effects of insulin. The effect of two different plasma insulin levels were investigated during hyperinsulinemic euglycemic clamps performed in 19-day pregnant rats. The rate of placental glucose utilization was increased by 35% ( p < 0.05) at physio- logical hyperinsulinemia (Table I) and by 100% ( p < 0.01) at maximal plasma insulin levels ( Fig. 2; Tables 1 and 2 ). By contrast, placental glucose utilization rate was not significantly stimulated by maximal plasma insulin level during euglycemic hyperinsulinemic clamps in 21-day pregnant rats (Fig. 2 ; Tables  1 and 2) .
Effect of fasting. Fasting was characterized by low blood glucose and by high blood ketone body concentrations in maternal and fetal circulations, whereas plasma insulin concentration was decreased only in the mothers (Table 3) . After a fast of 48 or 96 h (Fig. 3) , placental glucose utilization rates were decreased by 40% (p < 0.01) and 47% ( p < 0.01) respectively.
Effect of acute hyperketonemia. To know whether the decrease in placental glucose utilization observed during maternal fasting could be due to the rise in blood ketone bodies, an acute elevation of maternal and fetal blood ketone body concentrations was performed. During 0-hydroxybutyrate infusions to fed pregnant rats, placental glucose utilization rate remained unaltered 133 + 22 nmol/min/mg (n = 6) ( Table 3) .
DISCUSSION
The 2DG-6-P accumulated in the placenta represents the amount of glucose utilized by the tissue since every moleculer of glucose which enters the cell is phosphorylated before its incorporation into glycogen or its oxidation. Nevertheless, this technique does not allow identification of the metabolic fate of glucose within the placenta. The rate of glucose metabolism in the placenta is highly dependent on simultaneous variations of uterine blood flow and maternal glucose concentration ( 19) , and these two parameters are taken into account in the measurement of glucose utilization rate by the 2DG technique.
During a meal in the adult rat, the mean blood glucose concentration increases by 1.4 mmol/liter (I 8). This slight postprandial hyperglycemia could be sufficient to induce an increase in placental glucose utilization because of the high Km of glucose transport in the placenta (4, 20, 21). To test this hypothesis maternal hyperglycemic clamps were performed to increase maternal blood glucose by 1.4 mmol/liter. Indeed, the measurement of glucose utilization requires a steady state for glucose concentration and utilization achieved only during clamp experiments. Placental glucose utilization during hyperglycemic clamp was increased significantly on day 19 of pregnancy as a result of the enhanced blood glucose and plasma insulin concentrations.
Because during hyperglycemic clamps the effect of glucose and insulin cannot be discriminated, hyperinsulinemic euglycemic clamps were performed to test the effect of insulin per se. The effects of hyperinsulinemia on placental glucose utilization were characterized on day 19 of pregnancy by a 30% increase of physiological hyperinsulinemia (16) and by a 100% increase at the maximal concentration of insulin. Nevertheless, the stimulation of placental glucose utilization by insulin is relatively modest when compared to other insulin-sensitive tissues (1 3, 22, 23) . The small proportion (10-20%) of trophoblast in the placenta (24) which represents the metabolically active cells could explain the relatively modest effect of insulin when expressed per unit weight of placenta. The effect of exogenous insulin on placental glucose uptake is observed only when blood glucose is maintained at basal levels since, when blood glucose is allowed to decrease, placental glucose uptake was not modified by insulin (25) .
It has been shown that the placenta is endowed with numerous insulin receptors (26) and term human placentas are now commonly used to extract large amounts of insulin receptors (27) . The placental receptors resemble insulin receptors of other insulin-sensitive tissues such as adipose tissue or liver (27) suggesting that insulin may play a role in the regulation of placental metabolic function. Furthermore the rat is a species with an hemochorial placenta in which the microvilli come into direct contact with maternal blood. Thus, a control of placental glucose metabolism by insulin is more likely to occur in a hemochorial placenta than in a epitheliochorial placenta such as is present in the sheep (28) . It is noteworthy that on day 19 of gestation, the effect of insulin on placental glucose utilization is related to the maternal hyperinsulinemia since fetal insulinemia was not modified under the experimental conditions tested.
By contrast, on day 21 of pregnancy the placental glucose utilization rate was not stimulated during hyperglycemic clamps despite increases in blood glucose and plasma insulin levels. It should be noted that maternal plasma insulin concentration was increased by only 2-fold at this stage of pregnancy compared with the 6.5-fold increase on day 19 of pregnancy (29) . Furthermore insulin had no significant effect on placental glucose utilization, as evidenced by the results observed in the presence of high insulin concentrations in both maternal and fetal circulations. These results are in agreement with data obtained in perfused human term placenta in which insulin has no effect on 486 LETURQUE ET AL. 7 Difference significant for p < 0.01 when compared with fed state.
acutely increased blood ketone body concentrations to a level slightly lower than those observed after fasting and this increase induced no modification of placental glucose utilization. Thus, in conditions of normoglycemia, the placenta utilizes glucose as a primary energy substrate rather than ketone bodies. The present studies indicate that the rat placenta changes its rate of glucose utilization when exposed in vivo to conditions of mild hyperglycemia or to fasting. These alterations depend mostlv on chances in maternal blood ducose concentrations. In additibn, the himochorial rat is an insulin-sensitive organ before term. The perfusion of P-hydroxybutyrate into 1 Pday pregnant rats 16. Leturque A, Fern6 P, Burnol A-F, Girard J 1986 Glucose utilization rates and
